GE

289.77

-1.11%↓

RTX

158.21

-0.23%↓

CAT

449.81

+2.2%↑

GEV.US

614.86

-0.62%↓

BA

214.43

-0.11%↓

GE

289.77

-1.11%↓

RTX

158.21

-0.23%↓

CAT

449.81

+2.2%↑

GEV.US

614.86

-0.62%↓

BA

214.43

-0.11%↓

GE

289.77

-1.11%↓

RTX

158.21

-0.23%↓

CAT

449.81

+2.2%↑

GEV.US

614.86

-0.62%↓

BA

214.43

-0.11%↓

GE

289.77

-1.11%↓

RTX

158.21

-0.23%↓

CAT

449.81

+2.2%↑

GEV.US

614.86

-0.62%↓

BA

214.43

-0.11%↓

GE

289.77

-1.11%↓

RTX

158.21

-0.23%↓

CAT

449.81

+2.2%↑

GEV.US

614.86

-0.62%↓

BA

214.43

-0.11%↓

Search

Enovis Corp

Gesloten

SectorIndustrieën

32.14 -3.48

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

32.02

Max

33.85

Belangrijke statistieken

By Trading Economics

Inkomsten

19M

-37M

Verkoop

5.7M

565M

Winstmarge

-6.491

Werknemers

7,367

EBITDA

44M

67M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+45.95% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

327M

1.8B

Vorige openingsprijs

35.62

Vorige sluitingsprijs

32.14

Nieuwssentiment

By Acuity

50%

50%

210 / 458 Rangschikking in Industrials

Enovis Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 jan 2025, 23:28 UTC

Belangrijke Marktbewegers

Maplebear Up on S&P MidCap 400 Inclusion

Peer Vergelijking

Prijswijziging

Enovis Corp Prognose

Koersdoel

By TipRanks

45.95% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 48.63 USD  45.95%

Hoogste 75 USD

Laagste 32 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Enovis Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

9 ratings

7

Buy

2

Hold

0

Sell

Sentiment

By Acuity

210 / 458 Rangschikking in Industrieën

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
help-icon Live chat